Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology

van Beek, Nina; Kruger, Stine; Fuhrmann, Tarek; Lemcke, Susanne; Goletz, Stephanie; Probst, Christian; Komorowski, Lars; Di Zenzo, Giovanni; Dmochowski, Marian; Drenovska, Kossara; Horn, Michael; Jedlickova, Hana; Kowalewski, Cezary; Medenica, Ljiljana; Murrell, Dedee; Patsatsi, Aikaterini; Geller, Shamir; UZUN, SONER; Vassileva, Snejina; Zhu, Xuejun; Fechner, Kai; Zillikens, Detlef; Stocker, Winfried; Schmidt, Enno; Rentzsch, Kristin

doi:10.1016/j.jaad.2020.01.049

Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology

van Beek N., Kruger S., Fuhrmann T., Lemcke S., Goletz S., Probst C., ...More

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol.83, no.5, pp.1315-1322, 2020 (SCI-Expanded)

Publication Type: Article / Article
Volume: 83 Issue: 5
Publication Date: 2020
Doi Number: 10.1016/j.jaad.2020.01.049
Journal Name: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
Page Numbers: pp.1315-1322
Keywords: autoimmune bullous diseases, biochip, immunofluorescence, pemphigoid, pemphigus, EUROPEAN ACADEMY, GUIDELINE
Akdeniz University Affiliated: Yes

Abstract

Background: The current standard in the serologic diagnosis of autoimmune bullous diseases (AIBD) is a multistep procedure sequentially applying different assays. In contrast, the BIOCHIP Mosaic technology combines multiple substrates for parallel analysis by indirect immunofluorescence.